Astellas Pharma Inc (OTCPK:ALPMF) Q3 2021 Earnings Conference Call January 29, 2021 2:00 AM ET Company Participants Naoki Okamura – Corporate Executive Vice President, Chief Strategy Officer and Chief Financial Officer Yukio Matsui – Chief Commercial Officer Mike Kitagawa – Development Project Management Head Conference Call Participants Hidemaru Yamaguchi – Citigroup Securities Kazuaki Hashiguchi – Daiwa Securities Fumiyoshi Sakai – Crédit Suisse AG Motoya Kohtani – Nomura Securities Yoshitsugu Shitaka – A ...

Q3/FY2020 FINANCIAL RESULTS ENDED DECEMBER 31, 2020 Chief Strategy Officer and Chief Financial Officer Naoki Okamura Executive Vice President, Astellas Pharma Inc. January 29, 2021 CAUTIONARY STATEMENT REGARDING FORWARDLOOKING INFORMATION 2 In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management' ...

Astellas Pharma Inc. (OTCPK:ALPMY) Q2 2020 Earnings Conference Call October 30, 2020 1:00 AM ET Company Participants Kenji Yasukawa - President & Chief Executive Officer Naoki Okamura - Representative Director & Executive Vice President Yukio Matsui - Chief Commercial Officer Mike Kitagawa - Senior Vice President, Development Project Management Conference Call Participants Hidemaru Yamaguchi – Citigroup Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - Credit Suisse Akinori Ueda - Goldman Sachs Shinic ...

Q2/FY2020 FINANCIAL RESULTS ENDED SEPTEMBER 30, 2020 Kenji Yasukawa, Ph.D. President and CEO Astellas Pharma Inc. October 30, 2020 CAUTIONARY STATEMENT REGARDING FORWARDLOOKING INFORMATION 2 In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management's current assumptions and beliefs in light of the ...

Astellas Pharma Inc (OTCPK:ALPMF) Q1 2021 Earnings Conference Call August 4, 2020 3:00 AM ET Company Participants Naoki Okamura – Representative Director and Executive Vice President Mike Kitagawa – Senior Vice President of Development Project Management Yukio Matsui – Chief Commercial Officer Conference Call Participants Hidemaru Yamaguchi – Citigroup Kazuaki Hashiguchi – Daiwa Securities Fumiyoshi Sakai – Crédit Suisse Securities Seiji Wakao – Mitsubishi UFJ Morgan Stanley Securities Naoki Okamura Thank y ...

Q1/FY2020 FINANCIAL RESULTS ENDED JUNE 30, 2020 Naoki Okamura Representative Director, Corporate Executive Vice President, Chief Strategy Officer and Chief Financial Officer Astellas Pharma Inc. August 4, 2020 CAUTIONARY STATEMENT REGARDING FORWARDLOOKING INFORMATION 2 In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statem ...